77.89EUR-0.84%Mkt Cap: 101.54B $P/E: 24.061d ago
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelit…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap101.54B $
Enterprise Value120.26B $
Revenue (TTM)53.17B $
Gross Profit36.59B $
Net Income (TTM)8.49B $
Revenue/Share44.02 USD
Last Price77.89 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees74.8K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFR0000120578
Valuation
P/E (Trailing)24.06
P/E (Forward)11.00
PEG28.65
EV/EBITDA8.17
EV/Revenue2.26
P/S1.90
P/B1.34
EPS (TTM)3.24
EPS (Forward)7.06
52W Range
76.7055% of range78.88
52W High78.88 EUR
52W Low76.70 EUR
Profitability
Gross Margin72.07%
Oper. Margin21.03%
EBITDA Margin27.68%
Profit Margin16.72%
ROE10.95%
ROA6.16%
Growth
Revenue Growth14.60%
Earnings Growth-91.20%
Cash Flow & Leverage
Operating CF11.68B $
CapEx (TTM)3.85B $
FCF Margin12.88%
FCF Yield6.74%
Net Debt18.72B $
Net Debt/EBITDA1.27
Balance Sheet
Debt/Equity0.28
Current Ratio0.99
Quick Ratio0.49
Book Value/Sh57.77 EUR
Cash/Share5.300 EUR
Dividends
Fwd Div Rate4.120 EUR
Trail. Div Rate4.120 EUR
Div. Yield5.39%
5Y Avg Yield4.04%
Payout Ratio127.16%
Ex-Div DateMay 5, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.20B
Float1.08B
Insiders10.31%
Institutions42.95%
Technical
SMA 5075.58 (+3.1%)
SMA 20079.17 (-1.6%)
Beta0.28
S&P 52W Chg20.80%
Avg Vol (30d)10.22K
Avg Vol (10d)13.32K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—